Indeed, the patient displayed several risk factors for maternal/fetal complications other than exposure to GLP-1 RAs: first of all woman’s age, then obesity, suboptimal glycemic control, borderline elevated blood pressure, and contemporary exposure to statin (drug with well-known teratogenic effect). The gene discussed is GLP1R; the disease is obesity disorder.